Current status and confusion in comprehensive interventional therapy for hepatocellular carcinoma
In recent years, hepatocellular carcinoma (HCC) has become the second leading cause of cancer-related death worldwide. Due to the insidious onset of this disease, only 20%-30% of the patients with HCC have the opportunity for surgical resection or liver transplantation. At present, interventional th...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Hepatology
2016-01-01
|
| Series: | Linchuang Gandanbing Zazhi |
| Subjects: | |
| Online Access: | http://www.lcgdbzz.org/down.asp?id=7095 |
| Summary: | In recent years, hepatocellular carcinoma (HCC) has become the second leading cause of cancer-related death worldwide. Due to the insidious onset of this disease, only 20%-30% of the patients with HCC have the opportunity for surgical resection or liver transplantation. At present, interventional therapy has become the first choice for patients with intermediate-stage HCC and some patients with late-stage HCC, and more and more scholars have realized the importance and necessity of comprehensive interventional therapy for HCC. The comprehensive interventional therapy of transcatheter arterial chemoembolization (TACE) in combination with various methods (TACE combined with local treatment, TACE sequential surgery, or TACE combined with systemic treatment) provides many therapeutic approaches and achieves good therapeutic effects. However, the indications, timing, and recurrence and metastasis after treatment for such combination therapies await further investigation |
|---|---|
| ISSN: | 1001-5256 1001-5256 |